BOSTON – OPTIMAL LEFT MAIN TRIAL – Rationale, Design, and Latest Status
EBC 2020 - LIVE! BOSTON SCIENTIFIC – Sponsored Symposium: OPTIMAL LEFT MAIN TRIAL - Rationale, Design, and Latest Status.
EBC 2020 - LIVE! BOSTON SCIENTIFIC – Sponsored Symposium: OPTIMAL LEFT MAIN TRIAL - Rationale, Design, and Latest Status.
European Bifurcation Club 2019, EBC 2019 - Barcelona, Spain BOSTON SYMPOSIUM Megatron Synergy. The new addition to the synergy family Author: Yiannis Chatzizisis, MD, PhD, University of Nebraska Medical Center, USA ONGOING/ FUTURE WORK Testing the performance of Megatron with 2-stent techniques in a larger cohort of LM bifurcations Head-to-head comparison of Megatron with other second generation DES Testing the performance of new purpose-built stents dedicated to other segments of the coronary tree e.g, distal segments A large, virtual clinical trial to show improved morphologic and biomechanical endpoints (which serve as surrogates of clinical outcomes) with purpose-built stents.
European Bifurcation Club 2019, EBC 2019 - Barcelona, Spain BOSTON SYMPOSIUM LM bifurcation PCI with the novel Megatron Synergy Stent: a case based discussion - Introduction Author: Thierry Lefevre, MD, PhD, ICPS, France The dream of interventional cardiologist for LM disease A stent with a good radial strength With more than 2 connectors A good visibility A low risk of longitudinal compression An optimal scaffolding and drug delivery An easy side branch access
European Bifurcation Club 2018 - EBC 2018 - Brussels, Belgium BENCH TESTING Stent Development Author: Tim Mickley, Boston Scientific
European Bifurcation Club 2015 - EBC 2015 - Athens, Greece Boston Scientific - Gold sponsor meeting Next generation DES in bifurcation PCI Author: Mark Spence, Consultant Cardiologist Royal Victoria Hospital, Belfast
European Bifurcation Club 2018 - EBC 2018 - Brussels, Belgium BENCH TESTING Stent Design for Bifurcations Author: Tim Mickley R&D Engineering, Boston Scientific